Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NT5E | P21589 | 1/20 | 0.52 |
| ▸ | GJB2 | P29033 | 1/20 | 0.51 |
| ▸ | PTPN1 | P18031 | 8/20 | 0.51 |
| ▸ | CDC25B | P30305 | 8/20 | 0.51 |
| ▸ | TACR2 | P21452 | 3/20 | 0.50 |
| ▸ | PTPN2 | P17706 | 4/20 | 0.49 |
| ▸ | PTPN6 | P29350 | 4/20 | 0.49 |
| ▸ | PTPN11 | Q06124 | 4/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | CA9 | Q16790 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5476248 | 0.92 | NT5E (0.57) | NT5EPTPN1CDC25BTACR2PTPN2 | |
| SCHEMBL5470888 | 0.92 | NT5E (0.57) | NT5EPTPN1CDC25BTACR2PTPN2 | |
| SCHEMBL14414816 | 0.92 | NT5E (0.57) | NT5EPTPN1CDC25BTACR2PTPN2 | |
| SCHEMBL22677759 | 0.91 | NT5E (0.48) | NT5EGJB2PTPN1CDC25BTACR2 | |
| SCHEMBL18744568 | 0.91 | PTPN1 (0.57) | NT5EPTPN1CDC25BTACR2PTPN2 | |
| SCHEMBL7079633 | 0.91 | PTPN1 (0.57) | NT5EPTPN1CDC25BTACR2PTPN2 | |
| SCHEMBL8219749 | 0.91 | PTPN1 (0.57) | NT5EPTPN1CDC25BTACR2PTPN2 | |
| SCHEMBL7597560 | 0.91 | GJB2 (0.52) | NT5EGJB2PTPN1CDC25BTACR2 | |
| SCHEMBL5198380 | 0.90 | TACR2 (0.51) | NT5EGJB2PTPN1CDC25BTACR2 | |
| SCHEMBL5198375 | 0.90 | TACR2 (0.51) | NT5EGJB2PTPN1CDC25BTACR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030045706-A1 | Method for preparing functionalised beta-(1,3)-glucan derivatives | LABORATOIRES GOEMAR (FR) | 2003-03-06 | — | — | US | disclosed |